Daily ideas
M&T Bank earned $818 million in Q2 2026 with a 3.70% net interest margin and CRE balances up $1.1 billion; the 2026-10-16 report tests whether that rebound reaches average balances.
UnitedHealth's Q2 medical care ratio improved to 86.7% from 89.1% in 2025, aided by $860 million of favorable reserve development; the October 13 report tests whether that margin is real.
Lamb Weston ended fiscal 2026 with net sales of $6,612.3 million, volume up 7% and price/mix down 6%; the coming quarter tests whether the volume it bought with price can still pay for itself.
Anaptys booked $24.6 million of Jemperli royalty in Q1 2026, near the 8% first tier, yet sweeps every dollar to Sagard until $600.0 million is paid; the 10-KT tests the 2027 crossover.
Tamboran still books no revenue, lost US$9.41 million last quarter and holds US$101.9 million of cash; its FY2026 report must show whether first Beetaloo gas lifts the going-concern doubt.
RPM International closed fiscal 2026 with $7.86 billion of sales and a flat 41.4% gross margin, yet diluted EPS fell to $5.17; the coming quarter tests whether pricing still covers raw-material cost.
Ericsson posted Q2 2026 net sales of SEK 52.7 billion at a 48.4% adjusted gross margin; the October 15 report tests whether renegotiated price increases can offset component cost inflation.
MillerKnoll ended fiscal 2026 with net sales of $3,841.7 million, up 4.7%, while orders grew just 0.4% and backlog fell to $678.8 million; the question now is whether contract orders can grow again.
Pasqal posted EUR 16.5 million of 2025 revenue against a EUR 50.5 million operating loss; its first results since listing test whether EUR 15.3 million of 2026-scheduled backlog converts.
Citizens posted a 3.16% net interest margin and $1.30 diluted EPS in Q2 2026 with capital markets fees at $153 million; Q3 results test whether contracted repricing outruns rising deposit costs.
Manchester United booked £520.1m of nine-month revenue and £187.5m adjusted EBITDA yet still lost £14.3m; Q4 decides whether the finishing-position uplift is already recognized.
Travelers posted an 83.6% combined ratio and $2.2 billion of core income in Q2 2026 as commercial renewal pricing slowed to 4.8%; the Oct 16 report tests margin through hurricane season.
Worthington grew fiscal 2026 net sales 20% to $1,381.3 million while ClarkDietrich earnings kept falling; the Q1 FY2027 question is whether that venture has troughed.
State Street grew Q2 2026 revenue 17% to $4.048 billion at a 34.3% pre-tax margin; Q3 tests whether servicing fee growth comes from new mandates or higher markets.
Acuity's nine-month fiscal 2026 net sales rose 8.3% to $3,397.4 million, but lighting fell 1.2% while building controls rose 58.9%; the October 1 report is the first clean read on which trend holds.
Truist earned $1.23 in diluted EPS on 15.4% ROTCE in Q2 2026 while cutting full-year net interest income growth guidance to 1%-1.5%; Q3 tests whether commercial loans and fees cover consumer exits.
H.B. Fuller's April price increase lifted second-quarter adjusted gross margin to 34.2%; the Q3 report due 2026-09-24 tests whether the spread survives a guided mid-single-digit volume decline.
SLB posted $8.97 billion of second-quarter 2026 revenue as Middle East revenue fell 13% to $1.66 billion; the October 16 report tests whether the restart lifts service margins too.
Fastenal's Q2 2026 net sales rose 14.7% to $2.39 billion while gross margin fell 75 basis points to 44.6%; the October 14 Q3 report tests whether site wins or pricing drives growth.
Nine-month skier visits fell 12.5% but lift revenue slipped only 3.5%; Vail's September 28 report also sets the first fall checkpoint on a 10% pass unit shortfall.
